rs34757931
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PS1_ModeratePM2PP5_Very_Strong
The NM_021729.6(VPS11):āc.2536T>Gā(p.Cys846Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000527 in 1,613,916 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt.
Frequency
Consequence
NM_021729.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS11 | NM_021729.6 | c.2536T>G | p.Cys846Gly | missense_variant | 15/16 | ENST00000621676.5 | NP_068375.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS11 | ENST00000621676.5 | c.2536T>G | p.Cys846Gly | missense_variant | 15/16 | 1 | NM_021729.6 | ENSP00000481126 | P1 | |
VPS11 | ENST00000614944.4 | c.2506T>G | p.Cys836Gly | missense_variant | 15/16 | 2 | ENSP00000481807 | |||
VPS11 | ENST00000622309.4 | n.2721T>G | non_coding_transcript_exon_variant | 12/13 | 5 | |||||
VPS11 | ENST00000524454.1 | n.120-270T>G | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000116 AC: 29AN: 249276Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135230
GnomAD4 exome AF: 0.0000527 AC: 77AN: 1461712Hom.: 0 Cov.: 32 AF XY: 0.0000495 AC XY: 36AN XY: 727138
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74348
ClinVar
Submissions by phenotype
Hypomyelinating leukodystrophy 12 Pathogenic:4
Likely pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Nov 16, 2020 | The homozygous p.Cys846Gly variant in VPS11 was identified by our study in 1 individual with hypomyelinating leukodystrophy 12. The variant has been reported in 13 Ashkenazi Jewish individuals with hypomyelinating leukodystrophy 12 (PMID: 26307567, 27120463), segregated with disease in 6 affected relatives from 4 families (PMID: 26307567, 27120463). This variant has been identified in 0.26% (27/10352) of Ashkenazi Jewish chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs34757931). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. This variant has also been reported in ClinVar (Variation ID: 218366) as pathogenic by Baylor Genetics and OMIM. Of the 14 affected individuals, all of them were homozygotes, which increases the likelihood that the p.Cys846Gly variant is pathogenic (PMID: 26307567, 27120463). In vitro functional studies provide some evidence that the p.Cys846Gly variant may impact protein function (PMID: 26307567, 27120463, 32316234). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PP1_strong, PM3, PP3, PS3_moderate (Richards 2015). - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 04, 2019 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been reported at the homozygous state in multiple patients from Ashkenazi Jewish descent [PMID 26307567] - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 06, 2024 | Variant summary: VPS11 c.2533T>G/p.Cys845Gly (also known as c.2536T>G/p.Cys846Gly in Refseq) results in a non-conservative amino acid change in the encoded protein sequence. Three of three in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00012 in 249276 control chromosomes. c.2533T>G has been reported in the literature in multiple individuals affected with Hypomyelinating Leukodystrophy 12. These data indicate that the variant is very likely to be associated with disease. ClinVar contains an entry for this variant (Variation ID: 218366). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2015 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 08, 2021 | Published functional studies demonstrate a damaging effect: decreased protein stability compared to wildtype (Zhang et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31980526, 31092635, 29431110, 27473128, 26307567, 27120463) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This sequence change replaces cysteine, which is neutral and slightly polar, with glycine, which is neutral and non-polar, at codon 846 of the VPS11 protein (p.Cys846Gly). This variant is present in population databases (rs34757931, gnomAD 0.2%). This missense change has been observed in individuals with clinical features of VPS11-related conditions (PMID: 26307567, 27120463). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 218366). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt VPS11 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects VPS11 function (PMID: 26307567, 27120463). For these reasons, this variant has been classified as Pathogenic. - |
Leukoencephalopathy Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing;research | Baylor Genetics | Dec 17, 2015 | We identified it, homozygous, in 5 affected individuals in 3 Ashkenazi Jewish families. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at